MRK
Merck & Company Inc
NYSE: MRK · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$109.18
-1.60% today
Updated 2026-04-29
Market cap
$274.03B
P/E ratio
15.24
P/S ratio
4.22x
EPS (TTM)
$7.28
Dividend yield
2.94%
52W range
$71 – $124
Volume
9.8M
Merck & Company Inc (MRK) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $6.77B | $7.00B | $6.57B | $3.39B | $10.82B | $12.38B | $10.02B | $11.65B | $7.86B | $12.42B | $10.38B | $6.45B | $10.92B | $13.44B | $10.25B | $14.11B | $19.09B | $13.01B | $21.47B | $16.47B |
| Capital expenditures | $980.20M | $1.01B | $1.30B | $1.46B | $1.68B | $1.72B | $1.95B | $1.55B | $2.32B | $1.28B | $1.61B | $1.89B | $2.62B | $3.47B | $4.68B | $4.45B | $4.39B | $3.86B | $3.37B | $4.11B |
| Depreciation | $2.27B | $1.99B | $1.63B | $2.58B | $7.38B | $7.43B | $6.98B | $6.99B | $6.69B | $6.38B | $5.44B | $4.64B | $4.52B | $3.65B | $3.63B | $3.21B | $3.91B | $3.87B | $4.50B | — |
| Stock-based comp | $168.00M | $211.00M | $219.00M | $415.50M | $509.00M | $369.00M | $335.00M | $276.00M | $278.00M | $299.00M | $300.00M | $312.00M | $348.00M | $417.00M | $475.00M | $479.00M | $541.00M | $645.00M | $761.00M | $820.00M |
| Free cash flow | $5.79B | $5.99B | $5.27B | $1.93B | $9.14B | $10.66B | $8.07B | $10.11B | $5.54B | $11.14B | $8.76B | $4.56B | $8.31B | $9.97B | $5.57B | $9.66B | $14.71B | $9.14B | $18.10B | $12.36B |
| Investing cash flow | $-4.88B | $-2.81B | $-1.83B | $3.16B | $-3.50B | $-2.89B | $-6.80B | $-3.15B | $-374.00M | $-4.76B | $-3.21B | $2.68B | $4.31B | $-2.63B | $-9.44B | $-16.55B | $-4.96B | $-14.08B | $-7.73B | — |
| Financing cash flow | $-5.60B | $-4.87B | $-5.52B | $-1.64B | $-5.44B | $-6.90B | $-3.27B | $-5.99B | $-15.11B | $-5.39B | $-9.04B | $-10.01B | $-13.16B | $-8.86B | $-2.83B | $2.59B | $-9.12B | $-4.81B | $-7.03B | — |
| Dividends paid | $3.32B | $3.31B | $3.28B | $3.48B | $4.85B | $4.81B | $5.24B | $5.28B | $5.25B | $5.12B | $5.12B | $5.17B | $5.17B | $5.70B | $6.21B | $6.61B | $7.01B | $7.45B | $7.84B | $8.18B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $4.94B | $1.59B | $2.63B | $-80.00M | $2.17B | $-8.18B | $1.08B | $-2.01B | $-423.00M | $2.08B | $1.95B | $-2.02B | $-202.00M | $5.02B | — | — | — |